Valeant Pharmaceuticals International and Turing Pharmaceuticals are the focus of two probes in Congress seeking to examine why the companies raised the prices of medications sharply after acquiring them.

The chief executive of the giant investment bank whose collapse set off a panic which led to the US economic rescue package took home more than €222m since 2000, he told the US Congress.